Boothbay Fund Management’s Surmodics SRDX Stock Holding History

Boothbay Fund Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,767	Closed	-$561K	–	2341
2025 Q3	$561K	Buy	18,767 +17	+0.1%	+$567	0.01%	1090
2025 Q2	$557K	Hold	18,750	–	–	0.01%	870
2025 Q1	$572K	Hold	18,750	–	–	0.02%	808
2024 Q4	$743K	Hold	18,750	–	–	0.02%	731
2024 Q3	$727K	Buy	+18,750	New	+$758K	0.02%	850

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's SRDX Position: Q4 2025 in Review

Boothbay Fund Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 18,767 shares — an estimated $561K sold.

Boothbay Fund Management first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $743K in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Boothbay Fund Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Boothbay Fund Management sold 18,767 Surmodics shares in Q4 2025, an estimated $561K.
Boothbay Fund Management first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
Boothbay Fund Management's Surmodics position peaked at $743K in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.